UP!
| 2016-07-10 | Reiterated Rating | Brean Capital | Buy | $3.00 |
| 2016-05-06 | Reiterated Rating | Brean Capital | Buy | $3.00 |
| 2016-03-31 | Reiterated Rating | Brean Capital | Buy | $5.00 |
| 2016-03-23 | Lower Price Target | S&P Equity Research | $1.37 to $1.12 | |
| 2016-03-16 | Downgrade | Oppenheimer | Outperform to Market Perform | |
| 2016-03-16 | Downgrade | Oppenheimer Holdings Inc. | Outperform to Market Perform | |
| 2016-03-11 | Reiterated Rating | Brean Capital | Buy | $8.00 to $5.00 |
| 2016-03-10 | Downgrade | Needham & Company LLC | Buy to Hold | |
| 2016-03-08 | Reiterated Rating | Needham & Company LLC | Buy | |
| 2016-03-02 | Lower Price Target | JMP Securities | Market Outperform | $8.00 to $6.00 |
| 2016-02-09 | Boost Price Target | Brean Capital | Buy | $8.00 to $14.00 |
| 2015-11-06 | Lower Price Target | JMP Securities | Market Outperform | $8.00 |
| 2015-10-05 | Reiterated Rating | Brean Capital | Buy | $14.00 |
| 2015-09-22 | Reiterated Rating | Oppenheimer | Outperform | |
| 2015-09-10 | Reiterated Rating | JMP Securities | Market Outperform | |
| 2015-09-09 | Initiated Coverage | JMP Securities | Outperform | $9.00 |
| 2015-09-03 | Reiterated Rating | Brean Capital | Buy | $14.00 |
| 2015-08-10 | Lower Price Target | Brean Capital | Buy | $17.00 to $14.00 |
| 2015-08-07 | Lower Price Target | Needham & Company LLC | Strong-Buy | $12.00 to $10.00 |
| 2015-08-04 | Reiterated Rating | Brean Capital | Buy | $17.00 to $14.00 |
| 2015-07-28 | Reiterated Rating | Oppenheimer | Outperform | $13.00 |
| 2015-07-23 | Reiterated Rating | Brean Capital | Buy | |
| 2015-06-29 | Initiated Coverage | Brean Capital | Buy | $17.00 |
| 2015-05-04 | Set Price Target | Cantor Fitzgerald | Hold | $8.50 |
| 2015-04-28 | Lower Price Target | Needham & Company LLC | Strong-Buy | $16.00 to $12.00 |
| 2015-04-21 | Initiated Coverage | Piper Jaffray | Overweight | $14.00 |
| 2015-04-21 | Initiated Coverage | Piper Jaffray Cos. | Overweight | $14.00 |
| 2015-03-25 | Initiated Coverage | Oppenheimer | Outperform | $15.00 |
| 2015-03-12 | Downgrade | Cantor Fitzgerald | Buy to Hold | $12.00 to $11.00 |
| 2015-03-11 | Boost Price Target | JMP Securities | Market Outperform | $13.00 to $15.00 |
| 2015-02-26 | Boost Price Target | Needham & Company LLC | Strong-Buy | $12.00 to $16.00 |
| 2015-02-09 | Initiated Coverage | Cantor Fitzgerald | Buy | $11.00 |
| 2015-02-06 | Downgrade | Longbow Research | Buy to Neutral | |
| 2014-12-30 | Initiated Coverage | JMP Securities | Outperform | $13.00 |
| 2014-11-11 | Reiterated | Needham | Strong Buy | $10 to $12 |
| 2014-11-11 | Initiated Coverage | Avondale Partners | Outperform | |
| 2014-11-11 | Boost Price Target | Needham & Company LLC | Strong-Buy | $10.00 to $12.00 |
| 2014-05-27 | Upgrade | Aegis Capital | Hold to Buy | |
| 2014-05-27 | Upgrade | Citigroup Inc. | Hold to Buy | |
| 2014-05-27 | Upgrade | Aegis | Hold to Buy | |
| 2014-05-15 | Upgrade | Needham & Company LLC | Buy to Strong-Buy | $6.30 to $10.00 |
| 2014-04-14 | Reiterated Rating | Needham & Company LLC | Buy | |
| 2014-03-19 | Boost Price Target | Needham & Company LLC | $5.00 to $5.50 | |
| 2014-01-06 | Downgrade | Cantor Fitzgerald | Hold to Sell | |
| 2013-11-13 | Reiterated Rating | Needham & Company LLC | Buy | $6.00 to $5.00 |
| 2013-11-13 | Downgrade | Guggenheim | Buy to Neutral | $10.00 to $2.00 |
| 2013-11-13 | Upgrade | Cantor Fitzgerald | Sell to Hold | $2.00 |
| 2013-11-12 | Downgrade | Stifel Nicolaus | Buy to Hold | |
| 2013-10-21 | Downgrade | Aegis | Buy to Hold | $3.00 |
| 2013-10-01 | Reiterated Rating | Cantor Fitzgerald | Sell | $2.50 to $2.00 |
| 2013-05-15 | Reiterated | Cantor Fitzgerald | Hold | $7 to $3 |
| 2013-05-14 | Reiterated | Needham | Buy | $8 to $6 |
| 2012-12-12 | Reiterated | Cantor Fitzgerald | Buy | $17 to $15 |
| 2011-08-12 | Initiated | Stifel Nicolaus | Buy | $15 |
| 2011-06-30 | Initiated | Morgan Joseph | Buy | $28 |
| 2016-07-10 | Reiterated Rating | Brean Capital | Buy | $3.00 |
| 2016-05-06 | Reiterated Rating | Brean Capital | Buy | $3.00 |
| 2016-03-31 | Reiterated Rating | Brean Capital | Buy | $5.00 |
| 2016-03-23 | Lower Price Target | S&P Equity Research | $1.37 to $1.12 | |
| 2016-03-16 | Downgrade | Oppenheimer | Outperform to Market Perform |
There is presents forecasts of rating agencies and recommendations for investors about this ticker
In PTX 0 funds of 2213 total. Show all
| Fund name | Ticker shares |
|---|
| Name Relationship | Total Shares | Holding stocks |
|---|---|---|
| Smith James Edward Jr. | 9.20% (3498504) | PTX / |
| Collins Cooper C. President and CEO | 6.57% (2500046) | PTX / TXMD / |
| GOTTLIEB JAY | 1.63% (618250) | PTX / |
| Novak Terence Chief Operating Officer | 1.31% (500000) | PTX / |
| Vlahos William | 1.25% (474800) | PTX / |
| LOEB JAN H | 1.18% (448550) | ACFN / APFC / PTX / |
| Pearce Michael Cooper President and CEO | 0.75% (286667) | PTX / |
| Becker David Paul Chief Financial Officer | 0.53% (200000) | PTX / |
| Sedor John A | 0.38% (145807) | PTX / |
| Drysdale Douglas Chief Executive Officer | 0.25% (95161) | PTX / |
| Dorsey Brian SVP, Research | 0.23% (87426) | APRI / PTX / |
| Miao Graham G President and CFO | 0.17% (64035) | DCTH / PDII / PTX / |
| Blanchard Anthem H. | 0.12% (45000) | PTX / |
| BLAIR W BRADLEY II Chairman of the Board and CEO | 0.10% (37642) | HTA / PTX / |
| Pina Kenneth S VP, Gen Counsel and Comp Off | 0.04% (15554) | PTX / |
| ELMS STEVE | 0.03% (10000) | ADMA / AMBI / LOXO / PTX / |
| Smith Angus W. SVP, Chief Bus Off & PFO | 0.02% (8300) | PTX / |
| Clifford Tracy Simmons Chief Financial Officer | 0.02% (7506) | PTX / |
| Patel Sanjay S Chief Financial Officer | 0.02% (7000) | PTX / |
| Siegel Barry J Senior VP and General Counsel | 0.01% (5000) | PTX / |
| Whaley Glenn Interim VP Fin, PAO & Controll | 0.01% (3700) | PTX / |
| Golembiewski Michael Joseph VP Finance, Controller, CAO | 0.01% (3300) | PTX / |
UM